Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.50 (-2.00%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £26.46m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

28 Jul 2016 07:00

RNS Number : 4408F
Elektron Technology PLC
28 July 2016
Β 

28 July 2016

Β 

Elektron Technology plc

(AIM: EKT, "Elektron" or "the Company" or the "Group")

Β 

Trading Update

Β 

Ahead of its Annual General Meeting on Thursday 28th July 2016, Elektron Technology plc, the global technology group, provides an update on recent trading.

As already announced at the time of the full year results revenues in the six months ending 31 July 2016 are expected to be lower than those for the same period last year. The Group continues to experience declines in markets for some of its legacy products. Elektron remains committed to its twin strategies of delivering efficiency and productivity improvements in its established businesses and investing in new product development to generate future growth.

Also as previously stated, in the current financial year investment in new product development as well as scale up costs associated with Checkit are expected to absorb much of the cash flow from the established businesses. The Checkit development programme remains on track. The new generation Automated Monitoring module was fully launched towards the end of the first half of the year and a further Checkit solution for SMEs will be launched in the second half.

Group order intake has, until recently, been in line with expectations with the Group's book to bill ratio being 1.04:1 for the current year to date. The Group experienced a drop in orders both immediately before and after the Brexit vote. As a response to the effect on input prices as a result of the drop in sterling, Elektron took action to increase the vast majority of sterling based output prices. In addition the Group is implementing further cost saving initiatives. The Board remains cautious due to the current high level of uncertainty.

Following the previously announced sale of Agar Scientific for initial proceeds of Β£2.0 million, the Group net cash position is expected to be around Β£0.3m at 31 July 2016 compared to a net debt position of Β£1.6m as at 31 January 2016.

The Group expects to announce its results for the half year to 31 July 2016 on 22 September 2016.

Β 

John Wilson, Chief Executive of Elektron, said:

Β 

"Despite the current economic uncertainty, the Group continues to make progress in the delivery of new product development programmes in our growth brands, which the Board believes will significantly enhance shareholder value in the medium term."

Β 

For further information:

Β 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

finnCapΒ (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

Β 

Notes to Editors

Β 

Elektron conceives, designs and markets innovative engineered products and services for businesses that connect, monitor and control

Β 

We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

Β 

-- New waves of "aware" business applications: Checkit

-- Demand for ubiquitous power and data: Bulgin

-- Growth in high precision manufacture: Queensgate

Β 

In addition, Elektron owns a portfolio of well-established products and brands that provide cash flow as well as customer access and feedback.Β 

Β 

Forward looking statements

Β 

Statements contained in this trading statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated.Β To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTSEUFIWFMSELW
Date   Source Headline
29th Jul 20105:43 pmRNSHolding(s) in Company
29th Jul 20104:00 pmRNSResult of AGM
28th Jul 20107:00 amRNSProposed Issue of Equity
15th Jul 20109:37 amRNSHolding(s) in Company
5th Jul 20103:17 pmRNSAnnual Financial Report
5th Jul 20107:00 amRNSTrading Update
10th Jun 20107:00 amRNSFinal Results
9th Jun 20101:49 pmRNSHolding(s) in Company
19th Apr 20103:45 pmRNSHolding(s) in Company
8th Apr 201012:58 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSTrading Statement
6th Apr 20107:00 amRNSDirectorate Change
8th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSStatement re Possible Offer
19th Feb 201012:18 pmRNSDirector/PDMR Shareholding
16th Feb 20107:00 amRNSDirectorate Change
20th Jan 20103:07 pmRNSDirectorate Change
12th Jan 20107:00 amRNSOffer Update
12th Jan 20107:00 amRNSTrading update
27th Nov 20097:00 amRNSStatement re Possible Offer at 61p
8th Oct 20097:00 amRNSHalf Yearly Report
26th Aug 20094:44 pmRNSStatement re Hartest Holdings plc
19th Aug 20097:00 amRNSTrading Statement
17th Aug 20095:08 pmRNSDirector/PDMR Shareholding
30th Jul 200912:25 pmRNSResult of AGM
22nd Jul 200910:08 amRNSRe scrip dividend alternative
6th Jul 20097:00 amRNSAnnual Financial Report
1st Jul 20095:01 pmPRNStatement re Possible Offer
1st Jul 200911:22 amRNSStatement re Possible Offer
11th Jun 20097:00 amRNSFinal Results
4th Mar 20097:00 amRNSPre Close Trading Update
17th Feb 20092:39 pmRNSDirector/PDMR Shareholding
24th Nov 200812:52 pmRNSDirector/PDMR Shareholding
24th Oct 20084:05 pmRNSHolding(s) in Company
20th Oct 20084:16 pmRNSDirector/PDMR Shareholding
17th Oct 20084:07 pmRNSDirector/PDMR Shareholding
15th Oct 200810:04 amRNSHolding(s) in Company
13th Oct 20084:33 pmRNSDirector/PDMR Shareholding
6th Oct 200812:46 pmRNSDirector/PDMR Shareholding
11th Sep 20084:54 pmRNSHolding(s) in Company
4th Aug 20087:00 amRNSDirector/PDMR Shareholding
29th Jul 20085:22 pmRNSResult of AGM
23rd Jul 20087:00 amRNSDirector/PDMR Shareholding
15th Jul 20088:49 amRNSAnnual Report and Accounts
9th Jul 20087:00 amRNSDirector/PDMR Shareholding
8th Jul 20087:00 amRNSDirectorate Change
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
27th Jun 200812:53 pmRNSHolding(s) in Company
25th Jun 20082:09 pmRNSHolding(s) in Company
19th Jun 20088:28 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.